logo
Introduction
Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents
Oral Anticoagulants
Aspirin and Other Platelet-Active Drugs
Heparin
Hemorrhagic Complications of Anticoagulant Treatment
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
Therapeutic Use of n-3 Fatty Acids for Vascular Disease and Thrombosis
Use of Antithrombotic Agents During Pregnancy
Prevention of Venous Thromboembolism
Antithrombotic Therapy for Venous Thromboembolic Disease
Antithrombotic Therapy in Atrial Fibrillation*
Antithrombotic Therapy in Valvular Heart Disease
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Antithrombotic Agents in Coronary Artery Disease
Coronary Thrombolysis
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
Antithrombotic Therapy for Cerebrovascular Disorders
Making Decisions About Antithrombotic Therapy in Heart Disease*
New Antithrombotics
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
Medicolegal Implications of Consensus Statements
Antithrombotic Therapy in Children